Related Experiment Video
Updated: Jun 25, 2026

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
[Management of heart failure in Piedmont Region]
Nicolò Montali1, Marco Bobbio, Enrico Cerrato
1Cardiologia Universitaria Osp. Molinette (TO), Via Santorre di Santarosa 19-I-10131 Torino, Italy. nicolo.montali@gmail.com
Insights
Outpatient chronic heart failure (CHF) management in Piedmont shows high medication use but limited instrumental evaluations. This contrasts with international guidelines, suggesting potential areas for improved diagnostic resource allocation in CHF care.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Context:
- Congestive heart failure (CHF) is a growing concern in industrialized nations, marked by high incidence and reduced survival.
- Effective medical service organization and resource management are critical challenges in managing CHF.
- This study focuses on resource utilization for CHF in outpatient settings in Piedmont, Italy.
Purpose:
- To quantitatively evaluate the use of diagnostic and therapeutic resources for congestive heart failure (CHF) patients in Piedmont's outpatient departments.
- To assess the alignment of current resource use with international guidelines for CHF management.
Summary:
- A cross-sectional study analyzed data from 547 CHF patients across 12 outpatient departments.
- Patients had a mean age of 66.1 years, mean ejection fraction of 36.6%, with coronary artery disease being the most common etiology.
- High rates of medication prescription (ACE inhibitors, beta-blockers, aldosterone antagonists) were observed, alongside relatively low utilization of instrumental evaluations like echocardiography and coronary angiography.
Impact:
- Findings indicate that outpatients with chronic heart failure in Piedmont receive substantial pharmacotherapy.
- The study highlights a lower-than-recommended number of instrumental diagnostic evaluations for CHF patients.
- This suggests a potential gap between current clinical practice and international guidelines, impacting resource allocation and patient care optimization.
Background:
Congestive heart failure (CHF) represents an emerging problem in industrialized countries: it continues to be diagnosed at high rates and has an decreased survival time, raising new problems, such as the need of an adequate medical service organization and resource expenditure. Aim of this analysis was a quantitative evaluation of diagnostic and therapeutic resource use for CHF in outpatient departments in Piedmont, Italy.
Methods:
We performed a cross-sectional observational study, based on a two-month data collection in 12 outpatient departments dedicated to congestive heart failure. Information was obtained on each patient using a specific anonymous data collection form.
Results:
We obtained and analyzed for the study 547forms. Mean patient age was 66.1 years, mean ejection fraction was 36.6%. Coronary artery disease accounted for 34.6% of congestive heart failure cases, followed by idiopathic etiology (26.4%). Main comorbidities were diabetes (22.3%) and chronic obstructive pulmonary disease (17.7%). Sixty-nine% of patients received a medical treatment with angiotensin-converting enzyme (ACE) inhibitors, 72.6% with beta-blockers, 48.8% with aldosterone antagonists. As far as diagnostic resource use during a six-month period preceeding observation, 46.8% of patients underwent echocardiographic examination, 9.9% Holter ECG, 6.0% coronary angiography. Therapy was more often increased in patients who underwent an instrumental evaluation during the preceeding six-month period.
Conclusions:
Data suggests that in Piedmont outpatients with chronic heart failure receive a high drug prescription level and a small number of instrumental evaluations, as suggested in main international guidelines.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy VI: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System